icon icon
icon
icon
Ask
icon
icon

Spero Therapeutics

SPRO

SPRO Spero Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    SPRO Chart
    See on advanced chart >

    About

    Spero Therapeutics, Inc. was formed as Spero Therapeutics, LLC in December 2013 under the laws of the State of Delaware. The company is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel...
    Read More
    • Highlight
      A multi-asset, clinical-stage biopharmaceutical company focused on novel treatments for bacterial infections, including multi-drug resistant bacterial infections and rare diseases
      • Industry
      Pharmaceuticals
    • Exchange
      NASDAQ
    • Listing Date
      11/02/2017
    • Established Date
      Invalid Date
    • Full-time Employees
      46
    • Address
      675 Massachusetts Avenue 14th Floor Cambridge Massachusetts 02139
    • Tel
      1-857-2421600
    • Website
      www.sperotherapeutics.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock